Related Experiment Video
Updated: Apr 18, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
What is the role of sofosbuvir in treating hepatitis C infection?
1Lawrence Carey is a clinical associate professor in the Temple University School of Pharmacy and a lecturer in pharmacotherapeutics and former program director of the Philadelphia University PA program, both in Philadelphia, Pa. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Sofosbuvir, a nucleotide polymerase inhibitor, was approved in 2013 for treating hepatitis C infection in adults. This article reviews the use of sofosbuvir in combination with ribavirin with or without pegylated interferon.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Subviral Agents
Cystic Fibrosis: Management
Sinus disease and chronic...

